CD274 and esophageal squamous cell carcinoma: In a phase II clinical trial[46] comparing neoadjuvant PD-L1 inhibitor (socazolimab) plus chemotherapy versus chemotherapy alone in locally advanced ESCC, Yue et al.[47] subsequently performed MRD detection through postoperative cfDNA analysis.